Taro Pharmaceutical Industries SG&A Expense (Quarterly) Trends

Taro Pharmaceutical Industries Ltd (TARO)

42.48 +0.28 (+0.66%) USD | NYSE | Apr 25, 16:00

42.48 0.00 (0.00%) Pre-Market: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1990. Upgrade now.

Date	Value
December 31, 2023	50.41M
September 30, 2023	54.54M
June 30, 2023	55.86M
March 31, 2023	50.13M
December 31, 2022	49.86M
September 30, 2022	42.26M
June 30, 2022	56.12M
March 31, 2022	41.18M
December 31, 2021	24.84M
September 30, 2021	23.68M
June 30, 2021	23.98M
March 31, 2021	22.23M
December 31, 2020	22.80M
September 30, 2020	24.07M
June 30, 2020	22.25M
March 31, 2020	29.11M
December 31, 2019	20.93M
September 30, 2019	23.65M
June 30, 2019	19.72M
March 31, 2019	23.32M
December 31, 2018	23.88M
September 30, 2018	19.18M
June 30, 2018	23.58M
March 31, 2018	23.78M
December 31, 2017	21.83M

Date	Value
September 30, 2017	18.34M
June 30, 2017	24.25M
March 31, 2017	22.21M
December 31, 2016	20.31M
September 30, 2016	20.89M
June 30, 2016	22.25M
March 31, 2016	22.56M
December 31, 2015	22.87M
September 30, 2015	24.05M
June 30, 2015	22.89M
March 31, 2015	22.23M
December 31, 2014	21.34M
September 30, 2014	21.68M
June 30, 2014	22.39M
March 31, 2014	26.65M
December 31, 2013	21.90M
September 30, 2013	22.23M
June 30, 2013	20.95M
March 31, 2013	22.13M
December 31, 2012	20.75M
September 30, 2012	19.98M
June 30, 2012	20.28M
March 31, 2012	23.10M
December 31, 2011	21.93M
September 30, 2011	24.44M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

19.72M

Minimum

Jun 2019

56.12M

Maximum

Jun 2022

34.61M

Average

24.84M

Median

Dec 2021

SG&A Expense (Quarterly) Benchmarks